Lushang Freda Pharmaceutical Co (SHSE:600223) Cyclically Adjusted FCF per Share: ¥0.98 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:600223 Lushang Freda Pharmaceutical Co Ltd SHSE:600223
68 GF Score
Price ¥5.54
GF Value ¥6.57
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Lushang Freda Pharmaceutical Co Cyclically Adjusted FCF per Share?

Lushang Freda Pharmaceutical Co SHSE:600223 +0.91% 68 Cyclically Adjusted FCF per Share is ¥0.98 as of Mar. 2026. GuruFocus rates SHSE:600223 with a GF Score™ of 68/100 and a GF Value™ of ¥6.57 (Modestly Undervalued). The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Lushang Freda Pharmaceutical Co's adjusted free cash flow per share for the three months ended in Mar. 2026 was ¥-0.043. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is ¥0.98 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Lushang Freda Pharmaceutical Co's average Cyclically Adjusted FCF Growth Rate was 34.20% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 69.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Lushang Freda Pharmaceutical Co was 100.00% per year. The lowest was -49.40% per year. And the median was -10.90% per year.

As of today (2026-08-07), Lushang Freda Pharmaceutical Co's current stock price is ¥5.54. Lushang Freda Pharmaceutical Co's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2026 was ¥0.98. Lushang Freda Pharmaceutical Co's Cyclically Adjusted Price-to-FCF of today is 5.65.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Lushang Freda Pharmaceutical Co was 186.00. The lowest was 5.06. And the median was 13.08.


Lushang Freda Pharmaceutical Co  (SHSE:600223) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Lushang Freda Pharmaceutical Co's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=5.54/0.98
=5.65

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Lushang Freda Pharmaceutical Co was 186.00. The lowest was 5.06. And the median was 13.08.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Lushang Freda Pharmaceutical Co Cyclically Adjusted FCF per Share Related Terms


Lushang Freda Pharmaceutical Co Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Lushang Freda Pharmaceutical Co's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lushang Freda Pharmaceutical Co Cyclically Adjusted FCF per Share Chart

Lushang Freda Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.08 0.18 0.34 0.64 0.88

Lushang Freda Pharmaceutical Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.73 0.74 0.80 0.88 0.98

Lushang Freda Pharmaceutical Co Cyclically Adjusted FCF per Share Competitor Comparison

For the Real Estate - Development subindustry, Lushang Freda Pharmaceutical Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lushang Freda Pharmaceutical Co Cyclically Adjusted Price-to-FCF vs Real Estate Industry

For the Real Estate industry and Real Estate sector, Lushang Freda Pharmaceutical Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Lushang Freda Pharmaceutical Co's Cyclically Adjusted Price-to-FCF falls into.


SHSE:600223
68GF Score
Lushang Freda Pharmaceutical Co Ltd SHSE:600223
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Lushang Freda Pharmaceutical Co Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Lushang Freda Pharmaceutical Co's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.043/116.3033*116.3033
=-0.043

Current CPI (Mar. 2026) = 116.3033.

Lushang Freda Pharmaceutical Co Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201606 0.520 101.400 0.596
201609 -4.594 102.400 -5.218
201612 1.496 102.600 1.696
201703 0.590 103.200 0.665
201706 0.311 103.100 0.351
201709 0.560 104.100 0.626
201712 0.127 104.500 0.141
201803 -0.666 105.300 -0.736
201806 1.622 104.900 1.798
201809 0.194 106.600 0.212
201812 0.925 106.500 1.010
201903 0.394 107.700 0.425
201906 -4.116 107.700 -4.445
201909 -2.958 109.800 -3.133
201912 3.351 111.200 3.505
202003 -0.998 112.300 -1.034
202006 0.941 110.400 0.991
202009 1.544 111.700 1.608
202012 2.764 111.500 2.883
202103 0.211 112.662 0.218
202106 2.889 111.769 3.006
202109 1.310 112.215 1.358
202112 1.851 113.108 1.903
202203 -0.347 114.335 -0.353
202206 1.157 114.558 1.175
202209 0.269 115.339 0.271
202212 -0.193 115.116 -0.195
202303 0.047 115.116 0.047
202306 0.030 114.558 0.030
202309 0.073 115.339 0.074
202312 0.113 114.781 0.114
202403 -0.004 115.227 -0.004
202406 0.061 114.781 0.062
202409 -0.099 115.785 -0.099
202412 0.116 114.893 0.117
202503 -0.147 115.116 -0.149
202506 0.119 114.907 0.120
202509 -0.006 115.471 -0.006
202512 0.183 115.832 0.184
202603 -0.043 116.303 -0.043

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of ¥0.98 mean?
Lushang Freda Pharmaceutical Co (SHSE:600223) has a Cyclically Adjusted FCF per Share of ¥0.98 as of Mar. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Lushang Freda Pharmaceutical Co and its competitors.
Is Lushang Freda Pharmaceutical Co's Cyclically Adjusted FCF per Share too high?
Lushang Freda Pharmaceutical Co's current Cyclically Adjusted FCF per Share is ¥0.98. Overall, Lushang Freda Pharmaceutical Co has a GF Score™ of 68/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Lushang Freda Pharmaceutical Co's Cyclically Adjusted FCF per Share compare to competitors?
Lushang Freda Pharmaceutical Co's Cyclically Adjusted FCF per Share of ¥0.98 can be compared against companies in the Real Estate industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Real Estate company?
A good Cyclically Adjusted FCF per Share depends on the Real Estate industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Lushang Freda Pharmaceutical Co and its competitors. Lushang Freda Pharmaceutical Co's current Cyclically Adjusted FCF per Share is ¥0.98. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lushang Freda Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Lushang Freda Pharmaceutical Co (SHSE:600223) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥6.57, compared to a current price of ¥5.54 — trading 15.7% below its estimated fair value. The current Cyclically Adjusted FCF per Share is ¥0.98. Lushang Freda Pharmaceutical Co's overall GF Score™ is 68/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Lushang Freda Pharmaceutical Co (SHSE:600223), the current Cyclically Adjusted FCF per Share is ¥0.98 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Lushang Freda Pharmaceutical Co (SHSE:600223) Overvalued in 2026?

Based on GuruFocus' analysis, Lushang Freda Pharmaceutical Co stock appears to be undervalued. The current stock price of ¥5.54 is trading 15.7% below its estimated GF Value™ of ¥6.57. GuruFocus considers Lushang Freda Pharmaceutical Co to be Modestly Undervalued.

Key valuation signals for SHSE:600223:

  • Cyclically Adjusted FCF per Share: ¥0.98
  • GF Value™: ¥6.57 vs. price of ¥5.54 (15.7% below fair value)
  • GF Score™: 68/100 with 2 warning signs

No single metric tells the full story. See the SHSE:600223 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Lushang Freda Pharmaceutical Co Business Description

Address No. 9777 Jingshi Road, Building 5, Lixia District, Jinan City, CHN
Lushang Freda Pharmaceutical Co Ltd formerly Lushang Health Industry Development Co Ltd is a real estate developer in China. The company is engaged in the development of office buildings, infrastructure, apartments, and hotels.
68GF Score

Get the complete analysis for SHSE:600223

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥5.54
Price
¥6.57
GF Value